combination of mosunetuzumab with chop in dlbcl
Published 3 years ago • 67 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
1:30
exploring the use of atezolizumab in combination with r-chop in dlbcl
-
2:52
mosunetuzumab for chemotherapy-intolerant dlbcl
-
6:12
coalition: glofitamab r-chop or glofitamab pola-r-chp in patients with high-risk dlbcl
-
1:23
phoenix: ibrutinib in combination with r-chop for dlbcl
-
1:20
subcutaneous mosunetuzumab in r/r b-cell lymphoma
-
3:12
polarix: polatuzumab vedotin and r-chp superior to r-chop in dlbcl
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
10:23
cytocell hematology fish protocol (for use with cytocell aml and mds fish probe kits only)
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
2:56
upcoming trials for dlbcl: r-chop with acalabrutinib and obinutuzumab with checkpoint inhibitor
-
2:33
tailoring chemotherapy: r-chop dose attenuation in elderly dlbcl
-
1:27
atezolizumab plus r-chop in dlbcl: encouraging results
-
7:16
changes in the classification of dlbcl
-
2:18
the need for more effective, less toxic therapies in frontline dlbcl treatment
-
2:55
ibrutinib in combination with r-chop in dlbcl: does age make a difference?
-
7:09
mosunetuzumab: next-generation antibody for follicular lymphoma
-
5:12
the emerging potential of bispecific antibodies as monotherapy & in combination for b-cell lymphoma
-
4:40
reduced r-chop in favourable-prognosis dlbcl doesn't compromise outlook
-
1:14
exciting combinations under investigation in lymphoma
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis